150 related articles for article (PubMed ID: 31307816)
1. Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Sep; 45(9):1754. PubMed ID: 31307816
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma" [Eur J Surg Oncol 46 2 (2019) 263-271].
Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
Eur J Surg Oncol; 2020 May; 46(5):928. PubMed ID: 32165000
[No Abstract] [Full Text] [Related]
3. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
4. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
[TBL] [Abstract][Full Text] [Related]
5. Anti-Cytokeratin (CAM5.2) reagent directed against cytokeratin 8, not cytokeratin 18. Comment on "Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study. Eur J Surg Oncol. 2009; 35: 1065-1070.".
Lin CK; Yao CC; Tseng SW; Han CP
Eur J Surg Oncol; 2010 Apr; 36(4):428; author reply 429. PubMed ID: 20133104
[No Abstract] [Full Text] [Related]
6. Comment to: Ballardini B, Santoro L, Sangalli C, et al. The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol 2013. http://dx.doi.org/10.1016/j.ejso.2013.10.004.
Samorani D; Fogacci T; Frisoni G; Accardi FG; Panzini I; Tassinari D
Eur J Surg Oncol; 2014 Jun; 40(6):782-3. PubMed ID: 24650761
[No Abstract] [Full Text] [Related]
7. Re: Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30(8):807-16.
Meijnen P; Rutgers EJ
Eur J Surg Oncol; 2005 Oct; 31(8):927. PubMed ID: 15951151
[No Abstract] [Full Text] [Related]
8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual" [Eur. J. Surg. Oncol. 45 (6) (2019) 1046-1053].
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Sep; 45(9):1755-1756. PubMed ID: 31307815
[No Abstract] [Full Text] [Related]
10. De-escalation of axillary surgery in early breast cancer.
Jatoi I; Benson JR; Toi M
Lancet Oncol; 2016 Oct; 17(10):e430-e441. PubMed ID: 27733269
[TBL] [Abstract][Full Text] [Related]
11. Re: Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer, by Agarwal A, Heron D, Sumkin J, Falk J (J Surg Oncol 2005;92:4-8).
van Rijk MC; Nieweg OE
J Surg Oncol; 2006 Mar; 93(3):165-6. PubMed ID: 16482594
[No Abstract] [Full Text] [Related]
12. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis.
van Nijnatten TJ; Schipper RJ; Lobbes MB; Nelemans PJ; Beets-Tan RG; Smidt ML
Eur J Surg Oncol; 2015 Oct; 41(10):1278-87. PubMed ID: 26329781
[TBL] [Abstract][Full Text] [Related]
14. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer.
van der Ent FW; Kengen RA; van der Pol HA; Povel JA; Stroeken HJ; Hoofwijk AG
Ann Surg; 2001 Jul; 234(1):79-84. PubMed ID: 11420486
[TBL] [Abstract][Full Text] [Related]
15. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
16. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
17. Different criteria for radioactive sentinel lymph nodes has different impact on sentinel node biopsy in breast cancer patients.
Song XY; Yuan XM; Chen WJ; Pan T; Xie SD; Qin C; Lou C; Jin M; Wang LB; Wu JM
J Surg Oncol; 2007 Jun; 95(8):635-9. PubMed ID: 17252554
[TBL] [Abstract][Full Text] [Related]
18. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis.
Nottegar A; Veronese N; Senthil M; Roumen RM; Stubbs B; Choi AH; Verheuvel NC; Solmi M; Pea A; Capelli P; Fassan M; Sergi G; Manzato E; Maruzzo M; Bagante F; Koç M; Eryilmaz MA; Bria E; Carbognin L; Bonetti F; Barbareschi M; Luchini C
Eur J Surg Oncol; 2016 Jul; 42(7):919-25. PubMed ID: 27005805
[TBL] [Abstract][Full Text] [Related]
19. [The sentinel node biopsy in patients with breast cancer: recommendations for the introduction of this procedure. Dutch Working Group Sentinel Node Biopsy in Breast Cancer].
Ruers TJ; Roumen RM
Ned Tijdschr Geneeskd; 1998 Oct; 142(41):2237-40. PubMed ID: 9864498
[TBL] [Abstract][Full Text] [Related]
20. ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.
Li JW; Mo M; Yu KD; Chen CM; Hu Z; Hou YF; Di GH; Wu J; Shen ZZ; Shao ZM; Liu GY
PLoS One; 2014; 9(12):e114646. PubMed ID: 25504233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
